(Q47427289)

16 January 2018

title

Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting (English)

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

21 October 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

21 October 2022

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

21 October 2022

author name string

Kroneman H

1

1 reference

16 January 2018

Eikelboom BC

2

1 reference

16 January 2018

Knot EA

3

1 reference

16 January 2018

de Smit P

4

1 reference

16 January 2018

Groenland TH

5

1 reference

16 January 2018

de Maat MP

6

1 reference

16 January 2018

Van Urk H

7

1 reference

16 January 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

1650406

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1650406

21 October 2022

publication date

1 August 1991

1 reference

16 January 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0741521491700275?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

https://api.elsevier.com/content/article/PII:0741521491700275?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Journal of Vascular Surgery

21 October 2022

published in

1 reference

16 January 2018

volume

14

1 reference

16 January 2018

issue

2

1 reference

16 January 2018

page(s)

208-214

1 reference

16 January 2018

Heparin activity monitoring during vascular surgery

cites work

2

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Monitoring of heparin in vascular surgery

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Monitoring heparin and haemostasis during reconstruction of the abdominal aorta

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Anticoagulation in abdominal aortic aneurysm surgery: the approach of vascular surgeons in Great Britain and Ireland

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Monitoring of intraoperative heparinization in vascular surgery

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Heparinization in aortic surgery

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Heparin kinetics in vascular surgery

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery

21 October 2022

11

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Systemic heparin in major vascular operations

21 October 2022

12

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Intraoperative anticoagulation in cardiovascular surgery

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Home treatment for deep venous thrombosis with low-molecular-weight heparin

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Anticoagulant and lipolytic effects of a low molecular weight heparin fraction

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Intravenous and subcutaneous administration of Fragmin in deep venous thrombosis

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Assay of heparin in plasma using a chromogenic substrate for activated factor X

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Optimal methods of aortoiliac reconstruction

21 October 2022

25

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Heparin kinetics in venous thrombosis and pulmonary embolism

21 October 2022

26

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Experience with a Thrombin Clotting Time Assay for Measuring Heparin Activity

21 October 2022

27

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

The effect of a bolus injection of unfractionated or low molecular weight heparin during aortobifemoral bypass grafting

21 October 2022

28

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Binding of heparin on the surface of cultured human endothelial cells

21 October 2022

29

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Antiheparin activity in human endothelial cells

21 October 2022

30

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Vascular sequestration of heparin

21 October 2022

31

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

The fate of heparin in rabbits after intravenous injection; filtration and tubular secretion in the kidneys

21 October 2022

32

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

The disappearance of a low molecular weight heparin fraction (CY 216) differs from standard heparin in rabbits

21 October 2022

34

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Low molecular weight heparin half life is prolonged in haemodialysed patients

21 October 2022

35

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Disappearance of circulating anti-Xa activity after intravenous injection of standard heparin and of a low molecular weight heparin (CY 216) in normal and nephrectomized rabbits

21 October 2022

36

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model

21 October 2022

37

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Thrombin-antithrombin III-complex & fibrin degradation products in plasma: Surgery and postoperative deep venous thrombosis

21 October 2022

40

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

Plasma cross-linked fibrin degradation products fraction D in patients undergoing elective abdominal surgery

21 October 2022

41

1 reference

https://api.crossref.org/works/10.1067/MVA.1991.29897

21 October 2022

Identifiers

1 reference

16 January 2018

release_pf4rcqxizrdf7lgirdxlzlq3ee

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pf4rcqxizrdf7lgirdxlzlq3ee

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

1650406

1 reference

16 January 2018